Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis

Biomedicine and Pharmacotherapy

Volumn 93, Issue , 2017, Pages 1253-1260

  Zhang, Jianping ^a,c   Cui, Lijing ^b   Han, Xue ^a   Zhang, Yuanyuan ^a   Zhang, Xuan ^a,c   Chu, Xi ^b   Zhang, Fenghua ^a   Zhang, Ying ^a   Chu, Li ^a,c  

^a HEBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Hebei Key Laboratory of Integrative Medicine on Liver Kidney Patterns   (China)

Author keywords

Apoptosis; Cardiotoxicity; Doxorubicin; Inflammation; Oxidative stress; Tannic acid

Indexed keywords

CAPTOPRIL; CASPASE 3; CATALASE; CREATINE KINASE; CREATINE KINASE MB; DOXORUBICIN; ENDOTHELIN 1; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; MALONALDEHYDE; NITRIC OXIDE; PROTEIN C FOS; PROTEIN C JUN; SUPEROXIDE DISMUTASE; TANNIN; TUMOR NECROSIS FACTOR; ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; CYTOKINE; GLUTATHIONE; PROTECTIVE AGENT; TANNIN DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; B CELL LYMPHOMA CELL; CARDIAC MUSCLE; CARDIOMYOPATHY; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG MEGADOSE; HEART LEFT VENTRICLE; HEART PROTECTION; HEART TISSUE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; DRUG EFFECTS; INFLAMMATION; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; APOPTOSIS; CARDIOTOXICITY; CASPASE 3; CYTOKINES; DOXORUBICIN; GLUTATHIONE; INFLAMMATION; INTERLEUKIN-1BETA; MALE; MALONDIALDEHYDE; MYOCARDIUM; NF-KAPPA B; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TANNINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85025081601     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.07.051     Document Type: Article

References (64)

1. Simunek, T., Sterba, M., Popelova, O., Adamcova, M., Hrdina, R., Gersl, V., Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol. Rep. 61 (2009), 154–171.
2. Hortobagyi, G.N., Anthracyclines in the treatment of cancer. An overview. Drugs 54:Suppl. 4 (1997), 1–7.
3. Chan, K.Y., Xiang, P., Zhou, L., Li, K., Ng, P.C., Wang, C.C., et al. Thrombopoietin protects against doxorubicin-induced cardiomyopathy improves cardiac function, and reversely alters specific signalling networks. Eur. J. Heart Fail. 13 (2011), 366–376.
4. Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., Gianni, L., Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56 (2004), 185–229.
5. Olson, R.D., Mushlin, P.S., Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J. 4 (1990), 3076–3086.
6. Hou, G., Dick, R., Abrams, G.D., Brewer, G.J., Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice. J. Lab. Clin. Med. 146 (2005), 299–303.
7. Arola, O.J., Saraste, A., Pulkki, K., Kallajoki, M., Parvinen, M., Voipio-Pulkki, L.M., Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 60 (2000), 1789–1792.
8. Takemura, G., Fujiwara, H., Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog. Cardiovasc. Dis. 49 (2007), 330–352.
9. Kluza, J., Marchetti, P., Gallego, M.A., Lancel, S., Fournier, C., Loyens, A., et al. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene 23 (2004), 7018–7030.
10. Xiao, J., Sun, G.B., Sun, B., Wu, Y., He, L., Wang, X., et al. Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro. Toxicology 292 (2012), 53–62.
11. Bagchi, D., Bagchi, M., Stohs, S., Ray, S.D., Sen, C.K., Preuss, H.G., Cellular protection with proanthocyanidins derived from grape seeds. Ann. N. Y. Acad. Sci. 957 (2002), 260–270.
12. Frankel, E.N., Parks, E.J., Xu, R., Schneeman, B.O., Davis, P.A., German, J.B., Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins. Lipids 29 (1994), 233–236.
13. Kris-Etherton, P.M., Hecker, K.D., Bonanome, A., Coval, S.M., Binkoski, A.E., Hilpert, K.F., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113:Suppl. 9B (2002), 71S–88S.
14. Liu, X., Kim, J.K., Li, Y., Li, J., Liu, F., Chen, X., Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells. J. Nutr. 135 (2005), 165–171.
15. Athar, M., Khan, W.A., Mukhtar, H., Effect of dietary tannic acid on epidermal lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res. 49 (1989), 5784–5788.
16. Mukhtar, H., Das, M., Khan, W.A., Wang, Z.Y., Bik, D.P., Bickers, D.R., Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res. 48 (1988), 2361–2365.
17. Hamiza, O.O., Rehman, M.U., Tahir, M., Khan, R., Khan, A.Q., Lateef, A., et al. Amelioration of 1,2 Dimethylhydrazine (DMH) induced colon oxidative stress, inflammation and tumor promotion response by tannic acid in Wistar rats. Asian Pac. J. Cancer Prev. 13 (2012), 4393–4402.
18. Khan, N.S., Ahmad, A., Hadi, S.M., Anti-oxidant: pro-oxidant properties of tannic acid and its binding to DNA. Chem. Biol. Interact. 125 (2000), 177–189.
19. Hayatsu, H., Arimoto, S., Negishi, T., Dietary inhibitors of mutagenesis and carcinogenesis. Mutat. Res. 202 (1988), 429–446.
20. Cowan, M.M., Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12 (1999), 564–582.
21. Erdelyi, K., Kiss, A., Bakondi, E., Bai, P., Szabo, C., Gergely, P., et al. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol. Pharmacol. 68 (2005), 895–904.
22. Holderness, J., Hedges, J.F., Daughenbaugh, K., Kimmel, E., Graff, J., Freedman, B., et al. Response of gammadelta T Cells to plant-derived tannins. Crit. Rev. Immunol. 28 (2008), 377–402.
23. Inoue, M., Suzuki, R., Koide, T., Sakaguchi, N., Ogihara, Y., Yabu, Y., Antioxidant gallic acid, induces apoptosis in HL-60RG cells. Biochem. Biophys. Res. Commun. 204 (1994), 898–904.
24. Wiseman, L.R., Spencer, C.M., Dexrazoxane A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy. Drugs 56 (1998), 385–403.
25. Singal, P.K., Iliskovic, N., Li, T., Kumar, D., Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J. 11 (1997), 931–936.
26. Zhang, L., Wang, Y., Li, D., Ho, C.T., Li, J., Wan, X., The absorption distribution, metabolism and excretion of procyanidins. Food Funct. 7 (2016), 1273–1281.
27. Li, S., Sui, Y., Xiao, J., Wu, Q., Hu, B., Xie, B., et al. Absorption and urinary excretion of A-type procyanidin oligomers from Litchi chinensis pericarp in rats by selected ion monitoring liquid chromatography-mass spectrometry. Food Chem. 138 (2013), 1536–1542.
28. Smeriglio, A., Barreca, D., Bellocco, E., Trombetta, D., Proanthocyanidins and hydrolysable tannins: occurrence: dietary intake and pharmacological effects. Br. J. Pharmacol. 174 (2017), 1244–1262.
29. Hu, X., Wang, H., Lv, X., Chu, L., Liu, Z., Wei, X., et al. Cardioprotective effects of tannic acid on isoproterenol-induced myocardial injury in rats: further insight into ‘French paradox'. Phytother. Res., 2015.
30. Zhang, Y., Chu, X., Liu, L., Zhang, N., Guo, H., Yang, F., et al. Tannic acid activates the Kv7 4 and Kv7.3/7.5 K(+) channels expressed in HEK293 cells and reduces tension in the rat mesenteric arteries. J. Pharm. Pharmacol. 68 (2016), 494–502.
31. Chu, X., Guo, Y., Xu, B., Li, W., Lin, Y., Sun, X., et al. Effects of tannic acid, green tea and red wine on hERG channels expressed in HEK293Cells. PLoS One, 10, 2015, e0143797.
32. Zhu, F., Chu, X., Wang, H., Zhang, X., Zhang, Y., Liu, Z., et al. New findings on the effects of tannic acid: inhibition of L-type calcium channels: calcium transient and contractility in rat ventricular myocytes. Phytother. Res. 30 (2016), 510–516.
33. Chu, X., Wang, H., Jiang, Y.M., Zhang, Y.Y., Bao, Y.F., Zhang, X., et al. Ameliorative effects of tannic acid on carbon tetrachloride-induced liver fibrosis in vivo and in vitro. J. Pharmacol. Sci. 130 (2016), 15–23.
34. Naus, P.J., Henson, R., Bleeker, G., Wehbe, H., Meng, F., Patel, T., Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways. J. Hepatol. 46 (2007), 222–229.
35. Tikoo, K., Sane, M.S., Gupta, C., Tannic acid ameliorates doxorubicin-induced cardiotoxicity and potentiates its anti-cancer activity: potential role of tannins in cancer chemotherapy. Toxicol. Appl. Pharmacol. 251 (2011), 191–200.
36. Ibrahim, M.A., Ashour, O.M., Ibrahim, Y.F., El-Bitar, H.I., Gomaa, W., Abdel-Rahim, S.R., Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol. Res. 60 (2009), 373–381.
37. Turgut Cosan, D., Saydam, F., Ozbayer, C., Doganer, F., Soyocak, A., Gunes, H.V., et al. Impact of tannic acid on blood pressure: oxidative stress and urinary parameters in L-NNA-induced hypertensive rats. Cytotechnology 67 (2015), 97–105.
38. Gheorghiade, M., De Luca, L., Bonow, R.O., Neurohormonal inhibition in heart failure: insights from recent clinical trials. Am. J. Cardiol. 96 (2005), 3L–9L.
39. Cheng, H., Wang, S., Jo, Y.I., Hao, C.M., Zhang, M., Fan, X., et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J. Am. Soc. Nephrol. 18 (2007), 551–559.
40. Koshikawa, M., Mukoyama, M., Mori, K., Suganami, T., Sawai, K., Yoshioka, T., et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J. Am. Soc. Nephrol. 16 (2005), 2690–2701.
41. Singal, P.K., Iliskovic, N., Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339 (1998), 900–905.
42. Mantawy, E.M., El-Bakly, W.M., Esmat, A., Badr, A.M., El-Demerdash, E., Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress: inflammation and apoptosis. Eur. J. Pharmacol. 728 (2014), 107–118.
43. Fouad, A.A., Yacoubi, M.T., Mechanisms underlying the protective effect of eugenol in rats with acute doxorubicin cardiotoxicity. Arch. Pharm. Res. 34 (2011), 821–828.
44. Hill, M.F., Palace, V.P., Kaur, K., Kumar, D., Khaper, N., Singal, P.K., Reduction in oxidative stress and modulation of heart failure subsequent to myocardial infarction in rats. Exp. Clin. Cardiol. 10 (2005), 146–153.
45. Sathiavelu, J., Senapathy, G.J., Devaraj, R., Namasivayam, N., Hepatoprotective effect of chrysin on prooxidant-antioxidant status during ethanol-induced toxicity in female albino rats. J. Pharm. Pharmacol. 61 (2009), 809–817.
46. Rahman, I., Oxidative stress: transcription factors and chromatin remodelling in lung inflammation. Biochem. Pharmacol. 64 (2002), 935–942.
47. Elsharkawy, A.M., Mann, D.A., Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology 46 (2007), 590–597.
48. Abd El-Aziz, T.A., Mohamed, R.H., Pasha, H.F., Abdel-Aziz, H.R., Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin. Exp. Med. 12 (2012), 233–240.
49. Hettmann, T., DiDonato, J., Karin, M., Leiden, J.M., An essential role for nuclear factor kappaB in promoting double positive thymocyte apoptosis. J. Exp. Med. 189 (1999), 145–158.
50. Bozkurt, B., Kribbs, S.B., Clubb, F.J. Jr., Michael, L.H., Didenko, V.V., Hornsby, P.J., et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97 (1998), 1382–1391.
51. Pikkarainen, S., Kennedy, R.A., Marshall, A.K., Tham el, L., Lay, K., Kriz, T.A., Regulation of expression of the rat orthologue of mouse double minute 2 (MDM2) by H(2)O(2)-induced oxidative stress in neonatal rat cardiac myocytes. J. Biol. Chem. 284 (2009), 27195–27210.
52. Eferl, R., Wagner, E.F., AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003), 859–868.
53. Ray, N., Kuwahara, M., Takada, Y., Maruyama, K., Kawaguchi, T., Tsubone, H., et al. c-Fos suppresses systemic inflammatory response to endotoxin. Int. Immunol. 18 (2006), 671–677.
54. Kim, T., Yoon, J., Cho, H., Lee, W.B., Kim, J., Song, Y.H., et al. Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat. Immunol. 6 (2005), 211–218.
55. Huang, Y., Johnson, K.R., Norris, J.S., Fan, W., Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 60 (2000), 4426–4432.
56. Abbas, S., Abu-Amer, Y., Dominant-negative IkappaB facilitates apoptosis of osteoclasts by tumor necrosis factor-alpha. J. Biol. Chem. 278 (2003), 20077–20082.
57. Rouet-Benzineb, P., Gontero, B., Dreyfus, P., Lafuma, C., Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J. Mol. Cell. Cardiol. 32 (2000), 1767–1778.
58. Dou, W., Zhang, J., Zhang, E., Sun, A., Ding, L., Chou, G., et al. Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-kappaB signaling pathway. J. Pharmacol. Exp. Ther. 345 (2013), 473–482.
59. Lou, H., Danelisen, I., Singal, P.K., Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 288 (2005), H1925–30.
60. Nicholson, D.W., Thornberry, N.A., Apoptosis Life and death decisions. Science 299 (2003), 214–215.
61. Golstein, P., Controlling cell death. Science 275 (1997), 1081–1082.
62. Childs, A.C., Phaneuf, S.L., Dirks, A.J., Phillips, T., Leeuwenburgh, C., Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62 (2002), 4592–4598.
63. Xin, H., Liu, X.H., Zhu, Y.Z., Herba leonurine attenuates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells. Eur. J. Pharmacol. 612 (2009), 75–79.
64. Wang, S., Kotamraju, S., Konorev, E., Kalivendi, S., Joseph, J., Kalyanaraman, B., Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem. J. 367 (2002), 729–740.